Cargando…
Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists
Toll-like receptor 7 (TLR7) is activated in response to the binding of single-stranded RNA. Its over-activation has been implicated in several autoimmune disorders, and thus, it is an established therapeutic target in such circumstances. TLR7 small-molecule antagonists are not yet available for ther...
Autores principales: | Pal, Sourav, Ghosh Dastidar, Uddipta, Ghosh, Trisha, Ganguly, Dipyaman, Talukdar, Arindam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268101/ https://www.ncbi.nlm.nih.gov/pubmed/35807273 http://dx.doi.org/10.3390/molecules27134026 |
Ejemplares similares
-
Recent Advances on Small-Molecule Antagonists Targeting TLR7
por: Zheng, Haoyang, et al.
Publicado: (2023) -
Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019) -
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
por: Ganguly, Dipyaman, et al.
Publicado: (2009) -
Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations
por: Gentile, Francesco, et al.
Publicado: (2015) -
pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG
por: Wu, Jing, et al.
Publicado: (2019)